Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans

BACKGROUND: Targeting the N-methyl-d-aspartate receptor (NMDAR) is a major translational approach for treating negative symptoms of schizophrenia. Ketamine comprehensively produces schizophrenia-like symptoms, such as positive, cognitive and negative symptoms in healthy volunteers. The amplitude of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Psychiatry Neurosci
Päätekijät: Thiebes, Stephanie, Leicht, Gregor, Curic, Stjepan, Steinmann, Saskia, Polomac, Nenad, Andreou, Christina, Eichler, Iris, Eichler, Lars, Zöllner, Christian, Gallinat, Jürgen, Hanganu-Opatz, Ileana, Mulert, Christoph
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Joule Inc. 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5487274/
https://ncbi.nlm.nih.gov/pubmed/28556775
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/jpn.160187
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia